We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. AAPOS “believes there is a strong case for approving” ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
HDP-101, an ADC, received FDA fast track designation for multiple myeloma, highlighting its potential in addressing unmet medical needs. Phase 1/2a trials show HDP-101's promising efficacy and ...
– Enrollment remains ongoing in a Phase 2 proof-of-concept study of ALTO-101 in patients with CIAS – MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--$ANRO #FastTrack ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...
KSI-101 showed significant visual and anatomical improvements in MESI and DME, with a favorable safety profile in the APEX study. The bispecific mechanism of KSI-101 targets IL-6 and VEGF, offering ...
AP-101, AL-S Pharma’s amyotrophic lateral sclerosis (ALS) therapy, was safe and well tolerated and led to clinically meaningful benefits for breathing and survival after one year of treatment. “We are ...
VOY-101 gene therapy for GA showed safety and tolerability in phase 1, with no significant adverse effects observed. The therapy uses a single intravitreal injection to deliver CFH gene protection, ...
SCOTTSDALE (AZFamily) — East Valley drivers who usually use the Loop 101 will have to take alternate routes due to a major closure this weekend. According to the Arizona Department of Transportation, ...
Two decades after Jeezy helped define the trap genre with Let’s Get It: Thug Motivation 101, the Atlanta legend is back to elevate the sound that changed hip-hop. On July 26, exactly 20 years after ...
Shares of Mustang Bio (NASDAQ:MBIO) jumped on Monday after the company said that the U.S. FDA has granted orphan drug status to its CAR T-cell therapy, MB-101, for the treatment of astrocytoma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback